Live Quote · NASDAQDSGNHealthcare· Biotechnology

Design Therapeutics, Inc.

$15.64 6.68%(+$0.98)
TickerSpark Score
58/100
Mixed
73
Valuation
20
Profitability
15
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DSGN research report →

52-Week Range88% of range
Low
$3.52
Current
$15.64
High
$17.25
Company Overviewwww.designtx.com

About the company

Design Therapeutics, Inc. is a biopharmaceutical company in the preclinical phase that focuses on creating treatments for genetic conditions stemming from nucleotide repeat expansions. Its current pipeline targets Friedreich's Ataxia (FA), a severe, progressive, monogenic, and autosomal recessive disease.

CEO
Pratik Shah
IPO
2021
Employees
56
HQ
Carlsbad, CA, US

Price Chart

+325.00% · this period
$15.79$9.66$3.54Jul 02Dec 31Jul 02
Valuation
Market Cap
$976.83M
P/E
-13.03
P/S
0.00
P/B
4.41
EV/EBITDA
-13.99
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-33.07%
ROIC
-35.67%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-69,792,000 · -40.74%
EPS
$-1.22 · -38.64%
Op Income
$-79,467,000
FCF YoY
-25.56%
Performance & Tape
52W High
$17.25
52W Low
$3.52
50D MA
$12.58
200D MA
$9.96
Beta
1.66
Avg Volume
915.14K

Get TickerSpark's AI analysis on DSGN

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 9, 26George Simeonother30,000
Jun 9, 26Schmid John P.other30,000
Jun 9, 26LAPPE RODNEY Wother30,000
Jun 9, 26Gover Justin D.other30,000
Jun 9, 26Shapiro Davidother30,000
Jun 9, 26Berger Heather A.other30,000
Mar 31, 26Shapiro Davidother60,000
Mar 31, 26Shapiro Davidother7,500
Mar 31, 26Shapiro Davidother0
Jan 2, 26Storgard Chrisother250,000
Coverage · DSGN

Our DSGN coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on DSGN yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate DSGN report →
Internal Compare

Similar companies

Peers in the same neighborhood.